Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|January 16, 2018
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatmentAgostino Consoli, Gloria Formoso, Maria Pompea Antonia Baldassarre, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2020
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes SocietyRaffaele Napoli, Gloria Formoso, Salvatore Piro, et al.
Endocrine Reviews|May 12, 2012
The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseasesSabrina Prudente, Giorgio Sesti, Assunta Pandolfi, et al.
Diabetes & Vascular Disease Research|May 3, 2019
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndromeAngelo Avogaro, Enzo Bonora, Agostino Consoli, et al.
Diabetes, Obesity & Metabolism|February 9, 2018
Cardiovascular biomarkers in clinical studies of type 2 diabetesMaria P A Baldassarre, Andreas Andersen, Agostino Consoli, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 22, 2022
Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World AnalysisGian Paolo Fadini, Cristobal Morales, Irene Caballero, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 7, 2021
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination TherapiesGian Paolo Fadini, Olga Disoteo, Riccardo Candido, et al.
Diabetes/Metabolism Research and Reviews|May 27, 2020
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real worldMario Luca Morieri, Agostino Consoli, Giorgio Sesti, et al.
Clinical Therapeutics|June 11, 2004
Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitusParis Roach, Shan Bai, Bernard Charbonnel, et al.
Diabetes/Metabolism Research and Reviews|April 25, 2025
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World StudyBenedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, et al.
Pageof 10